Methods: A sample of 71 opioid-treated chronic pain patents provided demographic and clinical information through questionnaires and the MINI Psychiatric interview before completing a psychophysiological measurement protocol. These measures assessed trait mindfulness, trait positive and negative affect, opioid craving, and emotional reactivity. Participants were primarily low-income, white, and African American individuals. As a part of the psychophysiological protocol, participants completed a validated emotional regulation task during which they were asked to: (1) look at negative photos and notice whatever feelings naturally arise for them, and (2) reappraise negative photos by reinterpreting the meaning of the images. Participants were then asked to rate their positive and negative affect, level of pain, and level of opioid craving on visual analogue scales.
Results: We found that trait mindfulness is correlated with reappraisal efficacy (r = .28, p = .04). Concomitantly, trait mindfulness significantly predicted reappraisal efficacy after controlling for trait positive and negative affect (p = .02). We also found that reappraisal efficacy is significantly inversely correlated with opioid craving (r = .26, p = .05).
Conclusions and Implications: Our study provides the first evidence of the effect of trait mindfulness on a performance-based measure of reappraisal efficacy. Findings indicate that trait mindfulness may buffer opioid craving through the mechanism of increased reappraisal efficacy. The Mindfulness to Meaning Theory (MMT) asserts that mindfulness allows individuals to broaden attention to new information that supports positive reappraisal of life circumstances, which in turn motivates values-driven behavior and leads to an increased sense of meaning in life. Our findings align with the MMT given that chronic pain patients who are able to manage their opioid cravings through reappraisal may experience an accompanying ability to see beyond their desire for opioids.